The Motley Fool

Benjamin Sinclair

Why Amaya Inc. Shares Are Surging

Amaya Inc. (TSX:AYA)(NASDAQ:AYA) shares have increased by more than 10% as CEO David Baazov steps aside. More »

Valeant Pharmaceuticals Intl Inc.: Jim Chanos and the Original Short Thesis

Jim Chanos was short Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) before the company ran into problems. More »

3 Reasons to Buy Brookfield Asset Management Inc. Instead of a Listed Partnership

Brookfield Asset Management Inc. (TSX:BAM.A)(NYSE:BAM) offers better value than any of its listed partnerships. More »

Bombardier, Inc.: Will Federal Money Inhibit a Turnaround?

Bombardier, Inc. (TSX:BBD.B) may be prevented from cutting more jobs if it takes federal money. More »

Valeant Pharmaceuticals Intl Inc.: 2 Stories That Have Flown Under the Radar

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is fighting a multi-front war. More »

Is Eldorado Gold Corp. a Bargain at Under $4?

Eldorado Gold Corp. (TSX:ELD)(NYSE:EGO) shares haven't kept pace with other gold stocks. More »

Barrick Gold Corp. Has Come a Long Way in 1 Year

Barrick Gold Corp. (TSX:ABX)(NYSE:ABX) is showing signs of maturity. More »

Why the 20% Drop in Amaya Inc. Was Overdone

Amaya Inc. (TSX:AYA)(NASDAQ:AYA) fell further into bargain territory on Wednesday. More »

Should BlackBerry Ltd. Be Disappointed to Be Dumped by Facebook Inc.?

Facebook Inc. (NASDAQ:FB) will no longer support the BlackBerry Ltd. (TSX:BB)(NASDAQ:BBRY) OS. What does this mean? More »

Valeant Pharmaceuticals Intl Inc.: 3 Lessons From Bill Ackman’s Painful Experience

Bill Ackman has made mistakes with Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) that the rest of us can learn from. More »